Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDOrganogenesis Holdings Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.29 | -$0.29 | -$0.29 |
| Q2 2026 | 2 | -$0.40 | -$0.30 | -$0.35 |
| Q3 2026 | 2 | -$0.13 | -$0.12 | -$0.12 |
| Q4 2026 | 1 | $0.01 | $0.01 | $0.01 |
| Q1 2027 | 1 | -$0.21 | -$0.21 | -$0.21 |
| Q2 2027 | 1 | -$0.05 | -$0.05 | -$0.05 |
| Q3 2027 | 1 | -$0.02 | -$0.02 | -$0.02 |
| Q4 2027 | 1 | $0.05 | $0.06 | $0.06 |
| Q1 2028 | 1 | -$0.14 | -$0.13 | -$0.13 |
| Q2 2028 | 1 | -$0.01 | -$0.01 | -$0.01 |
| Q3 2028 | 1 | -$0.04 | -$0.04 | -$0.04 |
| Q4 2028 | 1 | $0.10 | $0.10 | $0.10 |
Organogenesis Holdings Inc Earnings Date And Information
Organogenesis Holdings Inc last posted its earnings results on Thursday, May 7th, 2026. The company reported $-0.37 earnings per share for the quarter, missing analysts' consensus estimates of $-0.29 by $0.08. The company had revenue of 37.23 M for the quarter and had revenue of 563.03 M for the year. Organogenesis Holdings Inc has generated $0 earnings per share over the last year ($0.15 diluted earnings per share) and currently has a price-to-earnings ratio of -16.62. Organogenesis Holdings Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Organogenesis Holdings Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/07/2026 | Q1 2026 | -$0.29 | -$0.44 | -0.15 | $43.26 M | $37.23 M |
| 02/26/2026 | Q4 2025 | $0.22 | $0.28 | 0.07 | $172.65 M | $225.07 M |
| 11/06/2025 | Q3 2025 | $0.21 | $0.11 | -0.1 | $134.12 M | $150.49 M |
| 08/07/2025 | Q2 2025 | $0.07 | -$0.10 | -0.17 | $103.41 M | $100.78 M |
| 05/08/2025 | Q1 2025 | $0.04 | -$0.17 | -0.21 | $90.77 M | $86.69 M |
| 02/27/2025 | Q4 2024 | -$0.03 | $0.05 | 0.08 | $109.61 M | $126.66 M |
| 11/12/2024 | Q3 2024 | $0.01 | $0.09 | 0.08 | $108.83 M | $115.18 M |
| 08/08/2024 | Q2 2024 | -$0.02 | -$0.13 | -0.11 | $121.30 M | $130.23 M |
| 05/09/2024 | Q1 2024 | -$0.02 | -$0.02 | 0 | $101.07 M | $109.98 M |
| 02/29/2024 | Q4 2023 | -$0.00 | -$0.00 | -0 | N/A | $99.65 M |
| 11/09/2023 | Q3 2023 | $0.01 | $0.02 | 0.02 | N/A | $108.53 M |
| 08/09/2023 | Q2 2023 | $0.03 | $0.04 | 0.02 | N/A | $117.32 M |
| 05/10/2023 | Q1 2023 | -$0.02 | -$0.02 | -0 | N/A | $107.64 M |
| 03/01/2023 | Q4 2022 | $0.05 | $0.06 | 0.01 | N/A | $115.52 M |
| 11/09/2022 | Q3 2022 | $0.06 | $0.00 | -0.06 | N/A | $116.86 M |
| 08/09/2022 | Q2 2022 | $0.08 | $0.07 | -0.01 | N/A | $121.40 M |
| 05/10/2022 | Q1 2022 | $0.05 | $0.00 | -0.05 | N/A | $97.12 M |
| 03/01/2022 | Q4 2021 | $0.08 | $0.40 | 0.32 | N/A | $128.56 M |
| 11/09/2021 | Q3 2021 | $0.06 | $0.10 | 0.04 | N/A | $113.75 M |
| 08/09/2021 | Q2 2021 | $0.07 | $0.16 | 0.09 | N/A | $123.20 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Organogenesis Holdings Inc Earnings: FAQ's
The conference call for Organogenesis Holdings Inc's latest earnings report can be listened to online.
The conference call transcript for Organogenesis Holdings Inc's latest earnings report can be read online.
Organogenesis Holdings Inc (:ORGO) has a recorded annual revenue of $563.03 M.
Organogenesis Holdings Inc (:ORGO) has a recorded net income of $37.03 M.Organogenesis Holdings Inc has generated $0.16 earnings per share over the last four quarters.
Organogenesis Holdings Inc (:ORGO) has a price-to-earnings ratio of -16.62 and price/earnings-to-growth ratio is 0.03.